Amy C Sherman - Concepedia

Author

Amy C Sherman

Also Known As

A Sherman, A. Sherman, Amy C Sherman, Amy C. Sherman, Amy Caryn Sherman, Amy Sherman, Angela Guo, Corey, Lawrence, I. Michael Goonewardene, Jennifer A. Johnson

114

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University Emory University HOPE Clinic National Institute of Allergy and Infectious Diseases

About

Amy C Sherman is an author at Brigham and Women's Hospital specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	651
2	Immunology	7	7	515
3	Public Health	1	1	136
4	Epidemiology	1	1	136
5	Molecular Biology	1	1	86

Amy C Sherman

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva Nora Pisanic, Pranay R. Randad, Kate Kruczynski, Journal of Clinical Microbiology	2020	258
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients Alana F. Ogata, Chi‐An Cheng, Michaël Desjardins, Clinical Infectious Diseases VaccinationMrna-1273 VaccineLongitudinal Plasma SamplesVaccine DevelopmentMrna-1273 Vaccine Recipients	2021	230
Influenza in the COVID-19 Era Daniel A. Solomon, Amy C Sherman, Sanjat Kanjilal JAMA VaccinationInfectious Disease EpidemiologyCross-protectionPreventive MedicineCovid-19 Era	2020	136
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara, Science Translational Medicine VaccinationGlobal DeploymentVaccine DevelopmentVaccine TargetAluminum Hydroxide	2022	107
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain Katherine Nabel Smith, Sarah A. Clark, Sundaresh Shankar, Science Dominant StrainsImmunologyViral PathogenesisMolecular BiologyViral Structural Protein	2022	86
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva Pranay R. Randad, Nora Pisanic, Kate Kruczynski,	2020	80
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, EBioMedicine	2022	71
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara, PubMed	2022	69
The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States Amy C Sherman, Ahmed Babiker, Andrew Sieben, Clinical Infectious Diseases	2020	62
Distinct and overlapping genomic profiles and antiviral effects of Interferon‐λ and ‐α on HCV‐infected and noninfected hepatoma cells Anita Kohli, X. Zhang, Jun Yang, Journal of Viral Hepatitis	2012	54

Page 1